Pharmaceutical and a host of other companies will be expected to voluntarily pay into a new fund covering their use of genetic data, the UN COP16 biodiversity summit agreed, but countries failed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback